Q3 2023 Holdings
Filed 2023-11-14 | 20 holdings | $238.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $33.5M | 1,126,579 | 14.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $17.4M | 1,810,246 | 7.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $17.3M | 1,775,415 | 7.2% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $16.8M | 1,124,459 | 7.0% |
| Biogen Inc(BIIB) | COM | 09062X103 | $16.6M | 64,676 | 7.0% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $16.2M | 886,143 | 6.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $14.6M | 495,168 | 6.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $14.4M | 118,401 | 6.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $12.8M | 111,045 | 5.4% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $11.7M | 807,969 | 4.9% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $10.9M | 994,756 | 4.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $10.5M | 112,473 | 4.4% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $10.4M | 577,101 | 4.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $9.7M | 109,685 | 4.1% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $9.1M | 1,219,093 | 3.8% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $7.0M | 982,458 | 2.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $5.0M | 10,074 | 2.1% |
| Morphic Hldg Inc | COM | 61775R105 | $3.1M | 136,743 | 1.3% |
| Jasper Therapeutics Inc | COM | 471871103 | $970.9K | 1,387,015 | 0.4% |
| Merus N V | COM | N5749R100 | $944.8K | 40,066 | 0.4% |